Articles tagged with Insulin
Researchers have discovered a potential target for the treatment of type 2 diabetes by inhibiting the S6K1 protein, which increases insulin sensitivity in mice. In animal models, S6K1 deficient mice displayed improved insulin response and reduced risk of developing diabetes.
Alternative drug-delivery systems are being explored to overcome syringe injection drawbacks, including ointments, dissolvable tablets and micro-needle skin patches. Several promising results have been shown in animal testing, but widespread adoption will require changing the mindset of pharmaceutical companies and regulators.
The study identified urocortin 3 as a key player in regulating insulin production and blood sugar levels. By understanding how this hormone interacts with other cells and systems, researchers hope to develop new treatments for diabetes.
A Montréal research team found that the dual-hormone artificial pancreas provides the most benefits by reducing time spent in nocturnal hypoglycaemia. The study also showed that no participant using the system experienced a nocturnal hypoglycaemia event requiring treatment.
Researchers have identified a gene that may help reactivate insulin-producing beta cells in diabetics. The team, led by Professor Tessem and including four students with Type 1 diabetes, has made significant breakthroughs in understanding the molecular pathways involved.
Diabetes research has made significant progress over the past 50 years, transforming treatment options and patient lives. The development of human insulin, improved glucose testing methods, and advanced delivery systems have greatly enhanced management of the condition.
A new study by Ohio State University researchers suggests that skipping meals can lead to insulin resistance and increased abdominal fat gain in mice. Mice on restricted diets who fasted for extended periods developed metabolic issues, including inflammation and plumper fat cells, compared to those who ate regularly.
In a study published in ETH Zurich, researchers discovered that the microRNA-200 family triggers the death of beta cells, leading to type 2 diabetes. By blocking miR-200 production, scientists can guarantee the survival of these vital cells. This finding has significant implications for the development of new treatments for diabetes.
Researchers found that larger spheres, at least 1.5 millimeters in diameter, triggered lower immune response and developed less scar tissue on their surface. This breakthrough could lead to a viable cure for type 1 diabetes by eliminating the need for lifelong immunosuppressive drugs.
Per capita health care spending for children with diabetes rose 4.1% in 2013, nearly double the 2012 increase, due to higher spending on branded insulin. Out-of-pocket costs for those with diabetes were more than double that of those without the disease.
Five teenagers with Type 1 diabetes will participate in a four-day study to test an 'artificial pancreas,' which automatically monitors and adjusts insulin delivery. The device has the potential to transform diabetes treatment by providing continuous glucose control, reducing anxiety for patients and parents.
Researchers found that eating more protein at breakfast lowered post-meal glucose levels and prompted cells to increase insulin concentrations at the second meal. Consuming 25-30 grams of protein at breakfast may be beneficial for individuals with type 2 diabetes, according to Jill Kanaley.
Researchers have successfully completed the first step in developing an insulin vaccine to prevent type 1 diabetes. The Pre-POINT study showed a positive immune response in children at high risk for the disease, with no adverse reactions observed.
A pilot study found that daily oral insulin administration induced an immune response without hypoglycemia, supporting the need for a phase 3 trial to prevent islet autoimmunity and diabetes. The study enrolled genetically at-risk children and showed varying responses to different doses of oral insulin.
Researchers found that children given daily doses of oral insulin developed a protective immune response to the disease, which could lead to the development of a vaccine against type 1 diabetes. The study showed increased immunity with higher doses of oral insulin, suggesting a potential treatment strategy.
Researchers at UC Davis may have discovered a new way to regenerate beta cells in the pancreas, which could potentially lead to a cure for juvenile diabetes. The study's findings suggest that immature beta cells can arise from alpha cells, offering a new paradigm shift in the treatment of the disease.
A study found that individuals on insulin experienced significantly higher levels of inflammation compared to those living in lower traffic areas. People taking oral diabetes medications did not show the same increase in inflammation, suggesting a potential protective effect.
Researchers at Columbia University Irving Medical Center have found a defect in pancreatic cells that can lead to high blood sugar levels and impaired glucose balance. An experimental drug called Rycal has been shown to stop the leaky channels and normalize glucose levels in mouse models.
A nationwide study found glyburide associated with increased risk of hospitalization, respiratory distress and hypoglycemia in newborns. In contrast, insulin showed lower risk for these outcomes.
Researchers at National Jewish Health found a response in human cells consistent with vaccination response in mice, using a mutated insulin fragment. The finding suggests an immune response in humans could lead to a vaccine and treatment for diabetes.
Researchers at University of British Columbia found a new approach to treating Type 2 diabetes using stem cell transplants and conventional drugs. The study showed mice became glucose tolerant after receiving the transplants, while those without received only drugs, resulting in unexpected weight loss.
A Johns Hopkins study reveals that drug companies have extended patents on insulin for over 90 years, preventing generic versions from entering the market. This has led to costly treatment options, with prices ranging from $120 to $400 per month, and hospitalizations due to uncontrolled diabetes.
Two major diabetes associations, EASD and ADA, jointly recommend a comprehensive overhaul of medical device safety in Europe and the US. The current regulatory framework is criticized for being too lenient, with a lack of follow-up studies and insufficient public availability of adverse event reports.
The American Diabetes Association and European Association for the Study of Diabetes call for a comprehensive safety overhaul of insulin pumps, including greater access to data from manufacturers and funding for independent clinical trials. This is crucial for healthcare teams to educate patients on preventing errors with these devices.
The ISFM Consensus Guidelines on the Practical Management of Diabetes Mellitus in Cats provide evidence-based advice for veterinary teams. Key findings include the importance of weight control, using appropriate diets, and insulin therapy, as well as close monitoring of blood glucose concentrations.
Researchers have identified three ways to predict the development of type 1 diabetes in young children based on autoantibody presence. The presence of these autoantibodies can indicate an autoimmune reaction against the body's own insulin cells, which may be triggered by a viral infection.
A new study published in Diabetologia shows that eating a high energy breakfast and a low energy dinner improves blood sugar control for individuals with type 2 diabetes. The study found significant reductions in post-meal glucose levels and insulin levels when participants followed the high-energy breakfast and low-energy dinner diet.
A new study published in Diabetologia found that lack of sleep can lead to elevated levels of free fatty acids in the blood, causing temporary pre-diabetic conditions in healthy young men. Insufficient sleep also results in increased insulin resistance, a hallmark of pre-diabetes, that persists for nearly five hours.
Researchers are developing an artificial pancreas (AP) to manage pediatric diabetes, aiming to alleviate parents' stress and anxiety. The device will be tailored to consider children's unpredictable eating habits and physical activity, and its safety, efficacy, reliability, and ease of use will be prioritized.
Researchers have developed a long-lasting, glucose-responsive insulin derivative called Ins-PBA-F, which self-activates when blood sugar levels rise. Tests on mouse models show that one injection works for up to 14 hours, automatically lowering blood sugar levels.
A Yale-led research team has discovered the molecular mechanism behind insulin's role in regulating liver glucose production and how it fails in patients with type 2 diabetes. The findings reveal that inflammation in fatty tissue leads to increased hepatic glucose production, highlighting a potential target for new treatments.
Researchers at Stanford University School of Medicine identified limostatin, a hormone that decreases insulin levels during recovery from fasting or starvation, in fruit flies and found a similar protein in humans. This discovery has critical ramifications for understanding metabolism and may inform new efforts to combat diabetes.
A new study identifies a DNA biomarker that can detect β cell death and predict type 1 diabetes risk. Unmethylated insulin DNA levels correlate with reduced β cell function and increased risk of clinical onset.
A study published in Molecular Metabolism found that adropin, a hormone regulating fat and sugar metabolism during feeding and fasting cycles, can improve insulin action in obese mice. This suggests that it may work as a therapy for type 2 diabetes.
Researchers at Saint Louis University have found a way to prevent type I diabetes in an animal model by blocking the autoimmune process that destroys beta cells. The study uses a selective ROR alpha and gamma t inverse agonist to reduce autoimmunity, suggesting a new treatment option for the illness.
A new study reveals that cone snails add a unique form of insulin to their venom cocktail, which disrupts blood glucose levels and causes hypoglycemic shock in fish. The snail insulin may help unlock secrets of insulin function and energy metabolism.
Researchers found that insulin nasal spray improved short-term verbal and visual information retention in adults with mild cognitive impairment and Alzheimer's. The study also showed significant benefits for those carrying the APOE-e4 gene, a risk factor for Alzheimer's.
Researchers discovered that triglyceride production in the liver is independent of insulin action, contributing to health risks in type 2 diabetics. The study's findings provide new insights into non-alcoholic liver disease and potential treatments.
A recent study published in Diabetes Care found that approximately one-third of people with type 1 diabetes produce insulin, as measured by C-peptide, even up to 40 years after diagnosis. This challenges the long-held assumption that these patients lose all ability to produce insulin, highlighting potential implications for clinical pr...
Researchers at Rockefeller University have successfully used electromagnetic waves to remotely control insulin production in diabetic mice, opening up new possibilities for treating diseases. The system, dubbed radiogenetics, uses a natural iron storage particle and heat-activated ion channel to trigger gene expression in cells.
A research team from Instituto Gulbenkian de Ciencia found that the timing of ecdysone synthesis is sensitive to nutrition in fruit flies, regulating final body size. Environmental conditions such as starvation and temperature control ecdysone production, affecting development and growth.
A new study published in Nature Communications reveals that cilia on pancreatic beta cells are covered with insulin receptors, and altered ciliary function is associated with type 2 diabetes. The research found that ciliary defects impaired insulin release, leading to elevated blood glucose levels in mice.
Diabetic patients using insulin pumps are at risk of dosing errors if they forget to change the clock on their devices. This can lead to severe consequences, including hypoglycemia and hyperglycemia. Researchers call for increased awareness and education to ensure proper pump settings.
Scientists aim to understand immune system factors that influence insulin production in people with type 1 diabetes. They hope to develop biomarkers and a drug combination to help people live with fewer complications and increased ability to manage their disease.
Patients treated first with metformin were less likely to require treatment intensification compared to those who started with sulfonylureas, thiazolidinediones, or DPP-4 inhibitors. Metformin also reduced the need for added insulin and was not associated with increased rates of hypoglycemia or cardiovascular events.
A new test developed by researchers at the University of Manchester can identify congenital hyperinsulinism in some patients without known genetic causes. The test measures hormone levels and may influence treatment options, including avoiding pancreatic removal.
Research finds that individuals with a history of depression and hostile marital relationships experience reduced calorie burn and higher insulin levels after consuming high-fat meals, leading to potential weight gain and metabolic syndrome. The study highlights the importance of treating mood disorders in preventing obesity.
Researchers at Lund University have developed a personalized treatment for type 2 diabetes that targets the disease mechanism itself, rather than just its symptoms. The treatment, which uses a drug called Yohimbin, has shown promising results in improving insulin secretion in patients with the genetic risk variant.
A team of scientists has successfully created a light-sensitive sulfonylurea compound that stimulates insulin release only in response to blue light. This breakthrough could lead to more precise control over blood sugar levels and reduce side effects associated with traditional diabetes treatments.
Researchers at Harvard University have made a breakthrough in producing human insulin-producing beta cells equivalent to normally functioning cells, offering hope for new diabetes treatment. The development involves massive quantities of human embryonic stem cells and could lead to drug discovery and transplantation therapy.
Researchers have discovered a new class of lipids in humans called fatty acid hydroxy fatty acids (FAHFAs) that are linked to reduced inflammation and improved blood sugar levels in diabetes. FAHFA levels are low in humans with a high risk for diabetes, suggesting potential therapeutic opportunities for metabolic disorders.
A new study at UC Berkeley found that mice fed a high-fat diet gained 18 percent less weight when drinking clarified grapefruit juice compared to water. The juice also improved glucose, insulin and triacylglycerol levels in mice.
A modified form of a medication called niclosamide may hold the key to battling type 2 diabetes by reducing liver fat and improving insulin function. The research aims to find a safe and practical way to diminish fat content in the liver, which could safely treat patients of all weights.
New research published in the BMJ suggests that long-acting insulin is superior to intermediate-acting insulin for controlling blood sugar levels, preventing weight gain, and treating severe hypoglycemia. Long-acting insulin also showed improved cost-effectiveness compared to intermediate-acting insulin.
Researchers at Karolinska Institutet found that age-dependent reduction of mitochondrial function in beta cells leads to reduced insulin release. Impaired calcium ion dynamics is the molecular mechanism underlying this process.
A nationwide study of over 18,000 patients with type 1 diabetes found that insulin pump treatment reduces all-cause mortality by 29% and fatal cardiovascular disease risk by 43%. Pump use was also associated with an 18% risk reduction for coronary heart disease.
A systematic review and meta-analysis found that combining basal insulin with a GLP-1 agonist resulted in improved blood sugar control, similar rates of hypoglycaemia, and greater weight loss compared to other anti-diabetic treatments. This combination therapy showed a 92% greater likelihood of achieving target blood sugar control.
Researchers found that high insulin levels foster processes leading to obesity, even in mice given insulin to counter diabetes. Suppressing glucagon action may prevent hyperinsulinemia without causing diabetes.
Researchers found that closed-loop insulin delivery systems maintained safe blood glucose levels for 53-82% of the time. The study proposed improvements needed for better design and implementation of these systems in adults and adolescents with type 1 diabetes.
Acute pancreatitis is a severe condition where the pancreas digests itself, leading to abdominal pain, vomiting, and systemic inflammation. Recent research suggests that insulin may prevent toxic effects of alcohol and fatty acid metabolites on pancreatic acinar cells.